GrantWise
HORIZON EUROPE TOPIC · Bridging actions

Advancing promising results from Pillar II collaborative research through the innovation journey

HORIZON-BRIDGING-2027-02-05 — the expected outcomes as checkable statements, what evaluators look for in this topic, and the conditions that shape the proposal.

Get the free Part B working draft for this topic ↓

ForthcomingIA · lump sumDeadline 28 January 2027around EUR 2.5 million per project

GrantWise › Horizon Europe topics › HORIZON-BRIDGING-2027-02-05

TopicHORIZON-BRIDGING-2027-02-05
StatusForthcoming
CallHORIZON-BRIDGING-2027-02 — Bridging actions 2027
Type of actionInnovation Actions · lump sum
Opening20 October 2026
Deadline28 January 2027
Budgetaround EUR 2.5 million per project · 13 projects expected · EUR 32.5 million in total
TRL at the endTRL 6
Part B page limit45 pages (standard application form; check your call)
TemplateWork Programme 2026–2027 application form

Expected outcomes

Projects should contribute to all of the expected outcomes. The topic says: “Project results are expected to contribute to all the following expected outcomes:”

  1. EO1 Research and Innovation (R&I) solutions funded under Horizon Europe Pillar II are further advanced along the innovation pathway towards uptake and deployment in the EU and/or Associated Countries, including their translation into high value products, services, processes or business models, strengthening the capacity of European public and private organisations to use innovative solutions.
  2. EO2 End users and market actors actively co-develop and validate highly innovative solutions in real-world settings, ensuring demand-side needs are integrated, helping to de-risk the innovation journey.
  3. EO3 The EU and Associated Countries benefit from accelerated commercialisation, adoption and deployment of Horizon Europe results, thereby reinforcing societal benefits, sustainable competitiveness, resilience and strategic autonomy of the Union.

What evaluators will look for in this topic

Expected outcomes

  • Projects should contribute to all of the expected outcomes.
  • For each outcome (EO1 to EO3), name who will use or adopt your results (a specific group, not “industry” or “society”), how they get them, and the indicator that shows the change, with baseline, target and date.
  • Use the topic's own words for each outcome, so the evaluator can tick it off.

What the scope asks for

Evaluators check the proposal against these sentences of the scope. Answer each one visibly, in the call's own words.

  • “Even though such results are many times successfully translated into used solutions, there is a need to increase the efficiency of the R&I investments and foster more uptake of promising results into innovative solutions.”
  • “Consortia do not necessarily have to include beneficiaries from the previous grant(s) but must own or have access to the knowledge assets, including intellectual property, where relevant, as stipulated in the specific conditions of this topic.”
  • “Applicants should justify the proposed composition of the consortium and how it brings the necessary expertise and results ownership.”
  • “Applicants should evidence that the proposed activities start beyond the laboratory or research environment and should focus on prototyping, testing, demonstrating, piloting, large-scale product validation and market replication under real-world conditions.”
  • “Proposals should focus on innovation activities that cover the later stages of development, including the use of research and technology infrastructures where relevant, should cover more than one of the following activities:.”
  • “Proposals should clearly outline which wider impact can be expected if the project succeeds, along with convincing Key Performance Indicators or a similar framework to measure and follow up the project impact.”
  • “Impacts do not have to be only monetary but can also consist of other kinds of societal benefits and impacts on wellbeing, clean transformation, resilience or strategic autonomy etc. To assess the value for investment, proposals should specify, with metrics where relevant, all the following:.”
  • “Proposals should identify the beneficiary(ies) (e.g. industry, company, public authority, etc.) responsible for the scaling-up of the solutions.”
  • “The exploitation strategy should envisage a first deployment in the EU and/or Associated Countries.”
  • “End users should be represented as a beneficiary within the consortium (and identified in the proposal) to test the feasibility of the solution and to ensure that the innovations developed meet the specific needs and requirements of the demand.”
  • “The maximum project duration should not exceed 3 years.”
  • “If the activities to be carried out under the proposal are relevant and align with STEP eligibility, (i.e. digital and deep tech, clean and resource efficient tech and biotech) proposals should demonstrate how they contribute to either: i) bringing innovative, cutting-edge technologies with strong economic potential to the internal market, or ii) reducing or preventing the Union’s strategic dependencies.”

Conditions that shape the proposal

  • Part B, sections 1–3: 45 pages (standard application form). Text beyond the limit is not read; tables and figures count.
  • Lump sum: the budget is fixed per work package and paid when each work package is completed. Every work package needs activities and deliverables an evaluator can verify, and the effort must match the money.
  • TRL: the topic expects TRL 6 by the end of the project. State where you start and the evidence for it.
  • Innovation action: evaluators expect a plausible path to commercialisation and named first users or customers.
  • Other Eligibility Conditions: “The following additional eligibility criteria apply: consortia may include a maximum of 6 independent eligible entities as participants.”
  • Other Eligibility Conditions: “The proposals must be based on results generated within a prior multi-beneficiary project funded directly under the Clusters of Pillar II (Clusters 1 to 6), through a Research and Innovation Action (RIA), an Innovation Action (IA) or a Pre-commercial Procurement Action (PCP). Applicants may submit a proposal based on…”
  • Other Eligibility Conditions: “The project(s) must have been completed before the submission deadline[[The ‘end date’ of the grant must be prior to the submission deadline.]]. Ongoing projects[[Projects that have an ‘end date’ after the submission deadline.]] are not considered eligible. Only projects where the granting authority for the completed…”
  • Other Eligibility Conditions: “Proposals must provide evidence[[In case of proposals that are based on results generated within more than one projects, evidence of ownership or access to the knowledge assets, including intellectual property where relevant, must be provided for all these projects.]] that the consortium owns or has access to the…”
  • Other Eligibility Conditions: “Commitment letter from the owner(s) of the relevant result(s) confirming the owner(s)’ willingness to negotiate fair, reasonable, and non-discriminatory access to the results, including IPR where relevant, for the purpose of future exploitation.”
  • Other Eligibility Conditions: “In line with the “restriction on control in innovation actions in critical technology areas” delineated in General Annex B of the General Annexes, entities established in an eligible country but which are directly or indirectly controlled by China or by a legal entity established in China are not eligible to…”

Impact pathway and traps

  • Users or citizens are part of the scope. Show how they take part in the design and testing, not only that they are informed.
  • The scope expects pilots or demonstration. Name the sites, the partners who run them and what is measured there.
  • Standardisation is mentioned. Name the committees or bodies and the partner who engages with them.
  • Market uptake is part of the scope. Evaluators look for a credible route to market with named first adopters.
  • Policy or regulation is in scope. Name the policy owners you will reach and what you will give them.
  • Keep outputs, outcomes and impacts apart: what you deliver, what changes when others use it, and the long-term effect.
  • Link your outcomes to the destination's expected impacts in the Work Programme. Destination impacts are long-term effects, not project deliverables.
  • Name the barriers outside the project (regulation, markets, user behaviour) that could block uptake, and what you will do if they do.
  • Section 2.3 (the summary canvas) is optional on this call; the old split into scientific, economic and societal impact is no longer required.
The scope, as published

Projects funded under Horizon Europe’s Pillar II generate a wealth of high potential innovative results. Even though such results are many times successfully translated into used solutions, there is a need to increase the efficiency of the R&I investments and foster more uptake of promising results into innovative solutions. If more results were converted into innovative products, processes, services, practices, business models or other novel solutions, they would strongly contribute to European societal benefit, sustainable competitiveness, prosperity, clean transformation, wellbeing or strategic autonomy. This topic aims at supporting actions that bring solutions generated by Pillar II closer to production and adoption by testing and validating them in real world settings, taking into consideration societal needs, cultural diversity and responsible innovation. Consortia do not necessarily have to include beneficiaries from the previous grant(s) but must own or have access to the knowledge assets, including intellectual property, where relevant, as stipulated in the specific conditions of this topic. Applicants should justify the proposed composition of the consortium and how it brings the necessary expertise and results ownership. Proposals may also build on complementary background results from closely related EU actions or national/regional projects contributing to the same innovation pathway, provided that these complementary results strengthen the market-readiness and deployment potential of the main result of the Horizon Europe project. Applicants should evidence that the proposed activities start beyond the laboratory or research environment and should focus on prototyping, testing, demonstrating, piloting, large-scale product validation and market replication under real-world conditions. Proposals should focus on innovation activities that cover the later stages of development, including the use of research and technology infrastructures where relevant, should cover more than one of the following activities: Validation and Testing activities: This could include refining or piloting of prototypes through iterative testing, ensuring they meet the required regulatory or other standards before moving forward; testing to gain approval from potential users, or trial in real-world settings, including to understand user preferences and/or optimise outcomes; stress testing for technical feasibility to ensure the robustness of solutions at scale. Commercialisation aspects: This could include activities around regulatory compliance standardisation or certification, development of business or pricing strategies and planning for market entry. Scaling and Operations: This could include activities around large scale validation such as interoperability and/or standardising processes for quality assurance and control; preparations for supply chains and operational readiness; planning for ramping up manufacturing or delivery. Stakeholder, User and Market Readiness: This could include activities that involve engaging users/customers through co-creation and iterative feedback mechanisms to refine products and strategies, and to ensure that the proposed solutions are aligned with industrial and/or societal needs, concerns and expectations. Deployment and Investment Bridging: This could include partnering activities to expands market reach and securing the required investment commitment for the next phase by EU or national deployment programmes or investment funds. Proposals should clearly outline which wider impact can be expected if the project succeeds, along with convincing Key Performance Indicators or a similar framework to measure and follow up the project impact. Impacts do not have to be only monetary but can also consist of other kinds of societal benefits and impacts on wellbeing, clean transformation, resilience or strategic autonomy etc. To assess the value for investment, proposals should specify, with metrics where relevant, all the following: Describe the expected scale and significance of the identified wider impacts. Include a business plan or exploitation strategy (including risks and mitigation) that will be further developed during the project. Proposals should identify the beneficiary(ies) (e.g. industry, company, public authority, etc.) responsible for the scaling-up of the solutions. The exploitation strategy should envisage a first deployment in the EU and/or Associated Countries. End users should be represented as a beneficiary within the consortium (and identified in the proposal) to test the feasibility of the solution and to ensure that the innovations developed meet the specific needs and requirements of the demand. To support the expected outcomes of the topic, additional end users beyond the project consortium can be subcontracted for further testing and validation activities. The maximum project duration should not exceed 3 years. If the activities to be carried out under the proposal are relevant and align with STEP eligibility, (i.e. digital and deep tech, clean and resource efficient tech and biotech) proposals should demonstrate how they contribute to either: i) bringing innovative, cutting-edge technologies with strong economic potential to the internal market, or ii) reducing or preventing the Union’s strategic dependencies. Where relevant, applicants envisaging to include clinical studies should provide details of their clinical studies in the dedicated annex using the template provided in the submission system.

Technology readiness, as published

The starting TRL for proposals based on results generated within a project funded under Cluster 3, 4, 5 or 6 should be TRL 6. For proposals based on results generated within a project funded under Cluster 1 or 2, the proposed activities must start beyond the laboratory or research environment and focus on prototyping, testing, demonstrating, piloting, large-scale product validation and market…

Source and attribution

Topic text from the official topic page on the EU Funding & Tenders Portal, retrieved 19 October 2026. © European Union, reused under Commission Decision 2011/833/EU (CC BY 4.0). Changes: the expected outcomes and impacts are split into numbered statements, long passages are shortened, and the evaluator checklist is GrantWise's own commentary. Your call and the Work Programme always win; check them before you submit. GrantWise is independent and not affiliated with, endorsed by, or acting on behalf of the European Commission.